Variant report

Variant	nsv1019563
Chromosome Location	chr9:11871596-12182937
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:12170667-12170713	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr9:12011400-12011402	GM12878	blood:	n/a	n/a
3	CBX3	chr9:12054451-12054644	K562	blood:	n/a	n/a
4	CEBPB	chr9:11933995-11934266	ECC-1	luminal epithelium:	n/a	chr9:11934105-11934116 chr9:11934106-11934117 chr9:11934105-11934118
5	CEBPB	chr9:11933909-11934318	Hela-S3	cervix:	n/a	chr9:11934105-11934116 chr9:11934106-11934117 chr9:11934105-11934118
6	CEBPB	chr9:12129071-12129335	HepG2	liver:	n/a	n/a
7	CEBPB	chr9:11968269-11968582	A549	lung:	n/a	chr9:11968445-11968456 chr9:11968447-11968456 chr9:11968446-11968457 chr9:11968445-11968458
8	CEBPB	chr9:11959566-11959766	K562	blood:	n/a	chr9:11959657-11959668
9	CEBPB	chr9:11968320-11968531	HepG2	liver:	n/a	chr9:11968445-11968456 chr9:11968447-11968456 chr9:11968446-11968457 chr9:11968445-11968458
10	CEBPB	chr9:11899316-11899547	A549	lung:	n/a	n/a
11	CEBPB	chr9:11933929-11934303	IMR90	lung:	n/a	chr9:11934105-11934116 chr9:11934106-11934117 chr9:11934105-11934118
12	CEBPB	chr9:12012267-12012412	A549	lung:	n/a	n/a
13	CEBPB	chr9:11946375-11946610	HepG2	liver:	n/a	chr9:11946481-11946492
14	CEBPB	chr9:12180768-12180970	IMR90	lung:	n/a	n/a
15	CEBPB	chr9:11959508-11959839	HepG2	liver:	n/a	chr9:11959657-11959668
16	CEBPB	chr9:12119993-12120079	A549	lung:	n/a	chr9:12120059-12120068 chr9:12120057-12120070 chr9:12120057-12120068
17	CEBPB	chr9:11946400-11946627	IMR90	lung:	n/a	chr9:11946481-11946492
18	CEBPB	chr9:11934067-11934195	HepG2	liver:	n/a	chr9:11934105-11934116 chr9:11934106-11934117 chr9:11934105-11934118
19	CEBPB	chr9:11959593-11959818	IMR90	lung:	n/a	chr9:11959657-11959668
20	CTCF	chr9:12092304-12092357	MCF-7	breast:	n/a	n/a
21	CTCF	chr9:12180880-12181030	HEK293	kidney:	n/a	n/a
22	CTCF	chr9:12053853-12053871	GM20000	blood:	n/a	n/a
23	CTCF	chr9:12045540-12045690	HPF	lung:	n/a	n/a
24	CTCF	chr9:12092315-12092389	MCF-7	breast:	n/a	n/a
25	CTCF	chr9:11952660-11952810	AG09319	gingival:	n/a	n/a
26	CTCF	chr9:11997160-11997310	HEK293	kidney:	n/a	n/a
27	CTCF	chr9:11906644-11906673	GM13976	blood:	n/a	n/a
28	CTCF	chr9:12092280-12092430	WERI-Rb-1	eye:	n/a	n/a
29	CTCF	chr9:12101680-12101830	GM12869	blood:	n/a	n/a
30	CTCF	chr9:12041004-12041085	GM20000	blood:	n/a	n/a
31	CTCF	chr9:12076206-12076321	GM10266	blood:	n/a	n/a
32	CTCF	chr9:11893413-11893434	Fibrobl	skin:	n/a	n/a
33	CTCF	chr9:12142395-12142451	LNCaP	prostate:	n/a	n/a
34	CTCF	chr9:12148949-12149036	Fibrobl	skin:	n/a	n/a
35	CTCF	chr9:12055107-12055140	GM13976	blood:	n/a	n/a
36	CTCF	chr9:12041600-12041634	GM20000	blood:	n/a	n/a
37	CTCF	chr9:12115897-12115954	GM10248	blood:	n/a	n/a
38	CTCF	chr9:11944302-11944336	GM13977	blood:	n/a	n/a
39	CTCF	chr9:12076187-12076204	GM10248	blood:	n/a	n/a
40	CTCF	chr9:12100160-12100310	NB4	blood:	n/a	n/a
41	CTCF	chr9:12180880-12181030	GM12878	blood:	n/a	n/a
42	CTCF	chr9:12078782-12078864	LNCaP	prostate:	n/a	n/a
43	CUX1	chr9:12116986-12116993	GM12878	blood:	n/a	n/a
44	E2F4	chr9:11931173-11931439	MCF10A-Er-Src	breast:	n/a	n/a
45	E2F4	chr9:12058071-12058393	MCF10A-Er-Src	breast:	n/a	n/a
46	E2F4	chr9:11981441-11981764	MCF10A-Er-Src	breast:	n/a	n/a
47	E2F4	chr9:11963927-11964296	MCF10A-Er-Src	breast:	n/a	n/a
48	E2F4	chr9:12058656-12058919	MCF10A-Er-Src	breast:	n/a	n/a
49	E2F4	chr9:12150860-12151087	MCF10A-Er-Src	breast:	n/a	n/a
50	E2F4	chr9:12080930-12081057	MCF10A-Er-Src	breast:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr18:21570976..21573123-chr9:12145530..12147030,2	MCF-7	breast:
2	chr9:12182493..12185046-chr9:12186407..12189303,2	K562	blood:
3	chr9:12094328..12096426-chr9:12096756..12098736,2	K562	blood:
4	chr9:12094328..12096426-chr9:12096756..12098736,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MPDZ-2	chr9:12098714-12099015	XLOC_007648
2	lnc-MPDZ-9	chr9:12088660-12089015	NONHSAT130219
3	lnc-MPDZ-2	chr9:12116821-12116865	XLOC_007648
4	lnc-MPDZ-2	chr9:12098660-12099015	XLOC_007648
5	lnc-MPDZ-2	chr9:12146273-12146401	XLOC_007648
6	lnc-MPDZ-9	chr9:12106821-12106865	NONHSAT130219
7	lnc-MPDZ-2	chr9:12159117-12159147	XLOC_007648
8	lnc-MPDZ-2	chr9:12139007-12139044	XLOC_007648
9	lnc-MPDZ-9	chr9:12136273-12136401	NONHSAT130219
10	lnc-MPDZ-2	chr9:12116821-12116865	XLOC_007648
11	lnc-MPDZ-9	chr9:12149117-12149147	NONHSAT130219

Variant related genes	Relation type
ENSG00000224935	TF binding region
ENSG00000168234	chromatin interactions

Extended variants
information (count: 4033 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:4033 , 50 per page) page: 1 2 3 4 5 6 7 ... 81

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35480085	chr9:11871620-11871621	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs182381705	chr9:11871647-11871648	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs544144246	chr9:11871662-11871663	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs1386304	chr9:11871701-11871702	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs529523524	chr9:11871712-11871713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs376770865	chr9:11871733-11871734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs542816435	chr9:11871751-11871752	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs73644924	chr9:11871778-11871779	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs528518131	chr9:11871780-11871781	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs199879136	chr9:11871791-11871792	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs10809627	chr9:11871800-11871801	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs562129175	chr9:11871808-11871809	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs201238009	chr9:11871811-11871812	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs186566941	chr9:11871850-11871851	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs377737509	chr9:11871870-11871871	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs73644925	chr9:11871906-11871907	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs569817391	chr9:11871929-11871930	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs139794311	chr9:11871931-11871932	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs541880390	chr9:11871954-11871955	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs555227426	chr9:11871995-11871996	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs149791583	chr9:11872007-11872008	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs534752610	chr9:11872042-11872043	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs557885616	chr9:11872054-11872055	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs577739683	chr9:11872060-11872061	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs543033041	chr9:11872074-11872075	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs145712040	chr9:11872096-11872097	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs140471168	chr9:11872102-11872103	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs543209317	chr9:11872110-11872111	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs72706181	chr9:11872147-11872148	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs573091159	chr9:11872171-11872172	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs556258175	chr9:11872182-11872183	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs78240461	chr9:11872188-11872189	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs73413166	chr9:11872238-11872239	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs550673761	chr9:11872253-11872254	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs144551431	chr9:11872256-11872257	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs146634914	chr9:11872258-11872259	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs549291435	chr9:11872260-11872261	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs565931078	chr9:11872348-11872349	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs534790937	chr9:11872377-11872378	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs551534377	chr9:11872387-11872388	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs571329415	chr9:11872388-11872389	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs537068300	chr9:11872400-11872401	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs556636914	chr9:11872408-11872409	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs574284235	chr9:11872414-11872415	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs572991752	chr9:11872439-11872440	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs536582759	chr9:11872481-11872482	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs540020968	chr9:11872514-11872515	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs73413167	chr9:11872540-11872541	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs191166498	chr9:11872554-11872555	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs545164680	chr9:11872583-11872584	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Disorders of sex development	21048976	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Cancer	20164920	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	21764851	CNVD
Glioblastoma multiforme	22286061	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Gastric cancer	16891809	CNVD
Mental retardation	17847001	CNVD
Cutaneous squamous cell carcinomas	17420988	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21611746	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Schizophrenia	18511947	CNVD
Type 2 diabetes	21526130	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Williams Syndrome	20824207	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:140 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:11869000-11871800	Weak transcription	Fetal Brain Female	brain
2	chr9:11871600-11871800	Enhancers	Pancreatic Islets	Pancreatic Islet
3	chr9:11871800-11872400	Enhancers	Fetal Brain Male	brain
4	chr9:11871800-11872600	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
5	chr9:11871800-11872800	Enhancers	Fetal Brain Female	brain
6	chr9:11874000-11874600	Enhancers	ES-I3 Cell Line	embryonic stem cell
7	chr9:11874000-11874600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr9:11874200-11874600	Enhancers	H1 Cell Line	embryonic stem cell
9	chr9:11874200-11874600	Enhancers	H9 Cell Line	embryonic stem cell
10	chr9:11874200-11874600	Enhancers	iPS-18 Cell Line	embryonic stem cell
11	chr9:11874200-11874600	Enhancers	iPS-20b Cell Line	embryonic stem cell
12	chr9:11874200-11874600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr9:11874200-11874800	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr9:11874200-11875000	Enhancers	HUES64 Cell Line	embryonic stem cell
15	chr9:11874200-11875400	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr9:11874600-11875800	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr9:11876000-11876200	Enhancers	H9 Cell Line	embryonic stem cell
18	chr9:11892600-11893200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr9:11892600-11893200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr9:11892800-11893600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr9:11892800-11894200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr9:11893000-11893400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr9:11893200-11894800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
24	chr9:11894600-11895000	Enhancers	K562	blood
25	chr9:11894800-11895400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr9:11901600-11911400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr9:11902200-11902800	Enhancers	Pancreatic Islets	Pancreatic Islet
28	chr9:11912400-11912600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr9:11914800-11915000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr9:11914800-11915600	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr9:11914800-11916600	Enhancers	HUES64 Cell Line	embryonic stem cell
32	chr9:11914800-11916600	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr9:11915000-11915600	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr9:11915000-11916000	Enhancers	iPS-20b Cell Line	embryonic stem cell
35	chr9:11915000-11916400	Enhancers	H1 Cell Line	embryonic stem cell
36	chr9:11915000-11916400	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr9:11915600-11915800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
38	chr9:11915600-11915800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
39	chr9:11915600-11915800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr9:11915600-11916000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr9:11915800-11916000	Enhancers	HUES48 Cell Line	embryonic stem cell
42	chr9:11915800-11916000	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr9:11916000-11916200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
44	chr9:11916000-11916200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
45	chr9:11916000-11916200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
46	chr9:11916200-11916400	Enhancers	HUES48 Cell Line	embryonic stem cell
47	chr9:11916200-11916400	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr9:11916200-11916400	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr9:11931000-11931400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr9:11931200-11932000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links